Ulrich Ernst

Entrepreneurial, results oriented leader in cell and gene therapy and biopharmaceuticals (process development, manufacturing, CMC, facility, quality and supply chain operations). Successful track record of bringing complex process operations through to commercialization and establishing cost-effective organizational structures. Multiple successes (4 biologics SOLIRIS, ADVATE, RECOTHROM; NATRECOR; 1 cell therapy - AMTAGVI) in gaining new product marketing authorizations and manufacturing facilities approvals. Key organizational leadership roles and broad scope of responsibility with multinational and development-stage firms covering P&L, business development, in-house/contract manufacturing, process development, quality, technology transfer, engineering, supply chain and global/US regulatory CMC.